Your browser is no longer supported. Please, upgrade your browser.
Illumina Inc.
Index- P/E81.54 EPS (ttm)2.38 Insider Own1.20% Shs Outstand143.80M Perf Week-3.43%
Market Cap27.91B Forward P/E49.68 EPS next Y3.91 Insider Trans-24.65% Shs Float142.08M Perf Month-2.97%
Income353.40M PEG3.63 EPS next Q0.72 Inst Own94.30% Short Float1.70% Perf Quarter1.13%
Sales1.86B P/S14.99 EPS this Y163.30% Inst Trans0.08% Short Ratio2.06 Perf Half Y8.36%
Book/sh10.28 P/B18.88 EPS next Y21.61% ROA11.10% Target Price224.75 Perf Year13.16%
Cash/sh9.31 P/C20.85 EPS next 5Y22.48% ROE26.20% 52W Range127.69 - 213.33 Perf YTD5.14%
Dividend- P/FCF77.71 EPS past 5Y34.90% ROI15.20% 52W High-9.03% Beta0.81
Dividend %- Quick Ratio2.40 Sales past 5Y22.80% Gross Margin69.70% 52W Low51.98% ATR5.05
Employees3700 Current Ratio2.60 Sales Q/Q32.30% Oper. Margin24.00% RSI (14)46.87 Volatility2.34% 2.24%
OptionableYes Debt/Eq0.88 EPS Q/Q83.90% Profit Margin19.00% Rel Volume0.82 Prev Close195.46
ShortableYes LT Debt/Eq0.67 EarningsJan 27 AMC Payout0.00% Avg Volume1.17M Price194.06
Recom2.00 SMA20-1.32% SMA500.76% SMA2009.05% Volume965,156 Change-0.72%
Jan-28-15Reiterated Stifel Buy $215 → $235
Jan-28-15Reiterated Maxim Group Buy $236 → $255
Jan-07-15Initiated Barclays Equal Weight $210
Oct-27-14Reiterated Stifel Buy $200 → $215
Oct-21-14Reiterated ISI Group Neutral $175 → $180.50
Aug-12-14Initiated Stifel Buy $200
Aug-01-14Initiated Tigress Financial Buy
Jul-24-14Reiterated Mizuho Buy $200 → $220
Jul-17-14Reiterated Maxim Group Buy $205 → $220
Apr-23-14Upgrade Maxim Group Hold → Buy $205
Apr-23-14Reiterated Mizuho Buy $175 → $200
Apr-23-14Reiterated ISI Group Neutral $152.50 → $162.50
Feb-19-14Reiterated UBS Buy $152 → $202
Jan-29-14Reiterated Mizuho Buy $150 → $175
Jan-29-14Reiterated ISI Group Neutral $134.50 → $147
Jan-17-14Reiterated Mizuho Buy $135 → $150
Jan-14-14Reiterated Mizuho Buy $125 → $135
Dec-19-13Reiterated Mizuho Buy $100 → $125
Oct-22-13Reiterated Mizuho Buy $86 → $100
Oct-22-13Reiterated Barclays Overweight $85 → $90
Feb-26-15 06:30AM  Illumina Accelerator Secures $40 Million Boost Capital to Back New Graduates Business Wire
Feb-25-15 08:00AM  10X Genomics Unwraps Its 'Toaster Oven' For Better DNA Sequencing at Forbes
Feb-24-15 11:19PM  Thermo Fisher Scientific, Ingersoll-Rand plc: Billionaires Are Piling Into These 5 Capital Goods Stocks at Insider Monkey
06:51PM  Illumina Expands NGS Portfolio with NeoPrep Library System - Analyst Blog Zacks
01:04PM  ILLUMINA INC Financials EDGAR Online Financials
08:00AM  Five Things To Watch For At The Big Genomics Event at Forbes
Feb-23-15 06:30AM  Illumina Launches the NeoPrep Library Prep System Business Wire
Feb-20-15 07:07PM  10-K for Illumina, Inc. Company Spotlight
01:10PM  What 23andMe's FDA Approval Means For The Future Of Genomics at Forbes
01:03AM  Illumina, Inc., Walgreens Boots Alliance Inc, Valeant Pharmaceuticals Intl Inc: Billionaire Halvorsens Top 3 Picks at Insider Monkey
Feb-19-15 10:15PM  In Big Shift, FDA Plans To Let 23andMe Market Genetic Tests To Consumers at Forbes
Feb-18-15 06:30AM  Illumina to Webcast Live Presentation at the Cowen and Company Annual Health Care Conference Business Wire
06:05AM  ILLUMINA INC Files SEC form 10-K, Annual Report EDGAR Online
Feb-16-15 07:15PM  Billionaire Stanley Druckenmillers Top 5 Picks Include Biogen Idec Inc (BIIB), Target Corporation (TGT), Home Depot Inc (HD) at Insider Monkey
Feb-13-15 05:08PM  Sony Betting Streaming Video Puts Its Comeback Into Focus at Investor's Business Daily
Feb-05-15 12:10PM  TrialReach Raises $13.5M Series B Led by Smedvig Capital PR Newswire
Feb-03-15 09:37AM  Illumina (ILMN) Stock Declines Today Despite Price Target Increase at TheStreet
08:35AM  Obama's New Healthcare Proposal: A Precise Vision Or A Political Football at Forbes
Feb-02-15 04:07PM  ILLUMINA INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
09:05AM  Why Illuminas outlook is so bright Market Realist
Jan-31-15 11:24AM  First Hand Account: The White House Precision Medicine Announcement at Forbes
Jan-30-15 06:39PM  Many Leading Stocks Stumble But Biogen, Harman Soar at Investor's Business Daily
03:05PM  Illuminas results beat analysts estimates Market Realist
12:15PM  Obama unveils precision medicine initiative CNBC
10:47AM  Viking Global Investors reduces its position in Illumina Market Realist
08:44AM  UK to launch 100,000 genomes project as Obama backs DNA drive Reuters
07:05AM  Reinventing pharma's next big frontier: Pro CNBC
07:03AM  White House targets precision medicine CNBC
06:00AM  Obama's $215 Million DNA Sequencing Project Is A Great Idea at Forbes
Jan-29-15 06:03PM  Top Earnings News: Illumina Back In Base Despite Beat at Investor's Business Daily
Jan-28-15 05:31PM  How To Invest: Use Weekly Stock Charts Like A Pro at Investor's Business Daily
04:46PM  Wednesday's Market Recap Yahoo Finance Contributors
04:21PM  Stocks Sell Off Into Close; Illumina, Yahoo Reverse Lower at Investor's Business Daily
03:00PM  Stock Indexes Turn Mixed; Apple Stays Strong at Investor's Business Daily
02:35PM  Illumina Q4 Results Trigger Price Target Increases at Investor's Business Daily
01:32PM  Nasdaq Recovers After Reversal; Apple Shines Brightly at Investor's Business Daily
09:30AM  Illumina Tops Q4 Earnings on Solid Revenues, Margin Growth - Analyst Blog Zacks
08:35AM  Why the Earnings Streak Will Continue for Illumina (ILMN) - Tale of the Tape Zacks
07:36AM  Illumina (ILMN) Earnings Report: Q4 2014 Conference Call Transcript at TheStreet
01:00AM  Obama's 'precision medicine' plan to boost research, but faces hurdles Reuters
Jan-27-15 06:47PM  Illumina beats on huge EPS rise Investor's Business Daily
05:12PM  Stocks Weaken Late; Apple Jumps After Hours at Investor's Business Daily
05:00PM  Illumina Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:48PM  Illumina beats Street 4Q forecasts AP
04:35PM  Rally Attempt Fizzles; Silicon Motion Recovers at Investor's Business Daily
04:10PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  Illumina Reports Record Financial Results for Fourth Quarter and Fiscal Year 2014 Business Wire
03:48PM  What to Expect When Illumina (ILMN) Reports Fourth-Quarter Earnings After Market Close Today at TheStreet
07:07AM  Q4 2014 Illumina Inc Earnings Release - After Market Close CCBN
Jan-26-15 06:42PM  Big Cap Stocks Mylan, American Tower Near Buy Points at Investor's Business Daily
Jan-23-15 06:34PM  IBD 50 Turns In Solid Week As Market Uptrend Resumes at Investor's Business Daily
02:00PM  Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst Blog Zacks
01:44PM  Putting the spotlight on Illumina at MarketWatch
09:30AM  Sequential Brands Group, Westlake Chemical, Hologic, McKesson and Illumina highlighted as Zacks Bull and Bear of the Day - Press Releases Zacks
08:46AM  Should You Buy Illumina (ILMN) Ahead of Earnings? - Tale of the Tape Zacks
Jan-22-15 05:50PM  Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog Zacks
12:45PM  Top 3 MedTech Stocks Poised to Gain this Earnings Season - Earnings ESP Zacks
Jan-21-15 05:09PM  3 High-Flying Health Care Stock IPOs To Watch In 2015 at Investor's Business Daily
02:49PM  Stocks Fade In Late Trade; Netflix Stays Strong at Investor's Business Daily
01:07PM  Midday movers: Exxon Mobil, Amazon, Boeing & more at CNBC
10:32AM  Stocks Narrowly Mixed, Dow Lags As IBM Revenue, Outlook Miss at Investor's Business Daily
06:30AM  Illumina Announces First Targeted Next-Generation Sequencing Solution for Forensic Genomics Business Wire
Jan-20-15 06:45PM  Illumina rose 7% Investor's Business Daily +7.02%
05:55PM  Illumina Makes Big Move Ahead Of Obama's Address at Investor's Business Daily
04:19PM  Taking Stock: Winners and Losers, Stock of the Day at Bloomberg
12:20PM  Will ResMed (RMD) Surprise Earnings Estimates in Q2? - Analyst Blog Zacks
Jan-16-15 02:30PM  Illumina Unveils 3 NGS Systems, Modifies Business Strategy - Analyst Blog Zacks
Jan-15-15 02:40PM  Illumina Declares Impressive Q4, 2014 Preliminary Results - Analyst Blog Zacks
Jan-14-15 05:30PM  Fluidigm's Preliminary Q4 Revenues Up Y/Y, Outlook Positive - Analyst Blog Zacks
07:00AM  Leader in Genomic Sequencing Illuminates the Way Morningstar
Jan-13-15 06:30AM  Illumina to Announce Fourth Quarter and Fiscal Year 2014 Financial Results on Tuesday, January 27, 2015 Business Wire
Jan-12-15 06:30PM  Hot Big Caps: Valeant, Illumina, Chipotle Break Out at Investor's Business Daily
04:23PM  Stocks Close Sharply Lower; Medicals Move On Announcements at Investor's Business Daily
03:04PM  Stocks Trade Near Session Lows; Illumina Tumbles at Investor's Business Daily
02:40PM  Lockheed Martin and Illumina to Collaborate on Developing Genomics Solutions to Improve Public Health and Wellness Business Wire
02:32PM  ILLUMINA INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
02:30PM  Illumina Expands Worlds Most Comprehensive Next-Generation Sequencing Portfolio Business Wire
08:00AM  Stealthy 10X Genomics Raises $55.5M To Beef Up DNA Sequencing at Forbes
01:05AM  Roche Spends $1.03 Billion For Majority Stake In Foundation Medicine at Forbes
Jan-11-15 07:00PM  £15m Initiative Puts Scotland at Forefront of Gene-Led Healthcare Business Wire
Jan-08-15 06:06PM  BioMed Realty Signs Deal To Build Campus For Illumina at Investor's Business Daily
10:40AM  Facebook, Chip Stocks Shine In Q4 Earnings Revisions at Investor's Business Daily
06:30AM  Illumina Announces African Orphan Crops Consortium to Receive Agricultural Greater Good Initiative Grant Business Wire
Jan-07-15 01:34PM  Stocks Stay Near Day's Highs, But Volume Eases Some at Investor's Business Daily
01:00PM  Coverage initiated on Illumina by Barclays
11:44AM  Adaptive Buys Sequenta to Disrupt Cancer Diagnosis, Drug Discovery at Forbes
Jan-06-15 07:51PM  Top Stock Buys And Sells: Illumina Favored at Investor's Business Daily
Jan-05-15 04:40PM  Illumina inks 15-year lease for massive BioMed project in Foster City at
04:11PM  ILLUMINA INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
04:01PM  BioMed Realty And Illumina To Create New 360,000 Square Foot World-Class Life Science Campus In Foster City, CA PR Newswire
11:48AM  Stocks Extend Morning Losses; Crude Oil Falls To New Low at Investor's Business Daily
10:33AM  Stocks Drop 1% In Rising Volume; Visa Falls 1% at Investor's Business Daily
Jan-02-15 10:31AM  Stocks Start New Year With Gains; Intel Jumps at Investor's Business Daily
Dec-31-14 04:53PM  Will Health Yield Wealth For Recent IPO INC Research? at Investor's Business Daily
Dec-30-14 05:16PM  Recent IPO PRA Health Sciences Finds Growth In Buyout at Investor's Business Daily
Dec-22-14 06:30AM  Illumina to Webcast Live Presentation at the J.P. Morgan Annual Healthcare Conference Business Wire
Dec-18-14 11:51AM  Stocks Up Big; Restoration, Accenture Hit New Highs at Investor's Business Daily
Dec-17-14 01:24PM  Stocks Hold Near Highs Ahead of Fed Announcement at Investor's Business Daily
Dec-15-14 01:29PM  Stocks Stage Comeback; Leaders Still Under Pressure at Investor's Business Daily
Dec-10-14 05:57AM  Kite Pharma (KITE) Shows Strength: Stock Moves Up 16.4% Zacks
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The company's products include sequencing platforms that are based on its SBS technology, which provides researchers with various ranges of applications and the ability to sequence mammalian genomes; and array platforms consist of HiScan and iScan systems, as well as NextSeq 550 system that are array scanners for DNA and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis. It also offers various library preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping, noninvasive prenatal test, and whole-genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FLATLEY JAY TChief Executive OfficerFeb 26Option Exercise33.8025,000844,875452,850Feb 27 06:53 PM
FLATLEY JAY TChief Executive OfficerFeb 26Sale195.7325,0004,893,227427,850Feb 27 06:53 PM
WALT DAVID RDirectorFeb 24Sale199.519,5031,895,975832,427Feb 26 07:57 PM
Bianchi Paul LSr VP Human ResourcesFeb 19Sale199.9916,9513,390,01274,667Feb 23 07:54 PM
WALT DAVID RDirectorFeb 17Sale197.985,000989,925841,930Feb 19 07:10 PM
WALT DAVID RDirectorFeb 17Sale198.102,000396,20070,960Feb 19 07:10 PM
FLATLEY JAY TChief Executive OfficerFeb 12Option Exercise22.7925,000569,775377,241Feb 13 07:38 PM
FLATLEY JAY TChief Executive OfficerFeb 12Sale194.6425,0004,865,990357,241Feb 13 07:38 PM
WALT DAVID RDirectorFeb 10Sale193.625,000968,090846,930Feb 12 07:45 PM
WALT DAVID RDirectorFeb 03Sale190.885,000954,381851,930Feb 05 08:14 PM
WALT DAVID RDirectorFeb 03Sale190.922,000381,83772,960Feb 05 08:14 PM
EASTHAM KARINDirectorFeb 02Option Exercise43.9210,000439,18516,226Feb 03 08:37 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Option Exercise69.3463243,82325,452Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Option Exercise69.3411,250780,07534,268Feb 02 09:28 PM
EASTHAM KARINDirectorFeb 02Sale192.7710,0001,927,7089,726Feb 03 08:37 PM
Bianchi Paul LSr VP, Human ResourcesFeb 02Sale195.371,035202,20857,715Feb 02 09:26 PM
Bouchard MichelVP, Finance & Chief AccountingFeb 02Sale195.37632123,47424,820Feb 02 09:26 PM
Naclerio NicholasSr VP & General ManagerFeb 02Sale193.0211,2502,171,45823,018Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Option Exercise43.374,000173,48028,129Feb 02 09:28 PM
Naclerio NicholasSr VP & General ManagerJan 30Sale198.174,000792,69124,129Feb 02 09:28 PM
WALT DAVID RDirectorJan 27Option Exercise6.234,00024,900860,930Jan 29 06:34 PM
WALT DAVID RDirectorJan 27Sale201.764,000807,047856,930Jan 29 06:34 PM
Dadswell CharlesSr VP & General CounselJan 27Sale198.9022444,55443,036Jan 28 07:00 PM
FLATLEY JAY TChief Executive OfficerJan 22Option Exercise20.0425,000501,000390,478Jan 23 08:06 PM
FLATLEY JAY TChief Executive OfficerJan 22Sale188.4825,0004,712,079365,478Jan 23 08:06 PM
WALT DAVID RDirectorJan 20Option Exercise6.234,00024,900860,930Jan 22 05:54 PM
RASTETTER WILLIAM HDirectorJan 20Option Exercise6.2316,00099,60021,953Jan 22 03:19 PM
RASTETTER WILLIAM HDirectorJan 20Sale188.9916,0003,023,8945,953Jan 22 03:19 PM
WALT DAVID RDirectorJan 20Sale194.432,000388,85474,960Jan 22 05:54 PM
WALT DAVID RDirectorJan 20Sale194.364,000777,420856,930Jan 22 05:54 PM
WALT DAVID RDirectorJan 13Option Exercise6.234,00024,900860,930Jan 15 07:42 PM
WALT DAVID RDirectorJan 13Sale187.064,000748,250856,930Jan 15 07:42 PM
FLATLEY JAY TChief Executive OfficerJan 08Option Exercise20.0425,000501,000390,478Jan 09 07:30 PM
FLATLEY JAY TChief Executive OfficerJan 08Sale197.6225,0004,940,542365,478Jan 09 07:30 PM
WALT DAVID RDirectorJan 06Option Exercise6.234,00024,900860,930Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.522,000377,03176,960Jan 08 06:28 PM
WALT DAVID RDirectorJan 06Sale188.564,000754,240856,930Jan 08 06:28 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Option Exercise69.3463143,75426,665Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Option Exercise36.2910,000362,90019,726Jan 05 07:35 PM
Bouchard MichelVP, Finance & Chief AccountingJan 02Sale186.17631117,47326,034Jan 05 07:35 PM
EASTHAM KARINDirectorJan 02Sale185.6310,0001,856,2519,726Jan 05 07:35 PM
WALT DAVID RDirectorDec 30Sale186.955,000934,741859,630Dec 30 06:28 PM
MOELLER GERALDDirectorDec 29Option Exercise42.818,000342,48025,457Dec 29 07:39 PM
Dadswell CharlesSr VP & General CounselDec 29Sale188.2014627,47743,260Dec 29 07:39 PM
MOELLER GERALDDirectorDec 29Sale187.058,0001,496,43917,457Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Option Exercise20.0425,000501,000390,478Dec 29 07:39 PM
FLATLEY JAY TChief Executive OfficerDec 26Sale186.7125,0004,667,817365,478Dec 29 07:39 PM
WALT DAVID RDirectorDec 23Sale184.565,000922,819864,830Dec 24 01:36 PM
WALT DAVID RDirectorDec 23Sale184.502,000369,00878,960Dec 24 01:36 PM
WALT DAVID RDirectorDec 16Sale178.355,000891,768869,630Dec 17 09:41 PM
Stapley MarcSr VP & CFODec 15Option Exercise36.301,42251,61925,706Dec 17 01:54 PM
Stapley MarcSr VP & CFODec 15Sale181.091,422257,50424,284Dec 17 01:54 PM
FLATLEY JAY TChief Executive OfficerDec 11Option Exercise20.0425,000501,000415,478Dec 12 07:00 PM
FLATLEY JAY TChief Executive OfficerDec 11Sale185.7925,0004,644,805390,478Dec 12 07:00 PM
WALT DAVID RDirectorDec 09Sale186.735,000933,645874,630Dec 11 08:02 PM
WALT DAVID RDirectorDec 09Sale186.792,000373,57680,960Dec 11 08:02 PM
BRADBURY DANIELDirectorDec 08Option Exercise42.821,60068,51214,066Dec 09 08:14 PM
BRADBURY DANIELDirectorDec 08Sale190.141,600304,21812,466Dec 09 08:14 PM
EASTHAM KARINDirectorDec 04Option Exercise42.8210,000428,20019,726Dec 05 07:54 PM
EASTHAM KARINDirectorDec 04Sale191.8710,0001,918,7259,726Dec 05 07:54 PM
Bouchard MichelChief Accounting OfficerDec 01Option Exercise69.3463143,75424,821Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Option Exercise44.3810,000443,80038,604Dec 02 05:35 PM
Bouchard MichelChief Accounting OfficerDec 01Sale187.43631118,26724,190Dec 02 05:36 PM
Ronaghi MostafaSr VP & CTODec 01Sale188.4610,0001,884,64528,604Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Option Exercise20.0425,000501,000406,262Dec 02 05:35 PM
Dadswell CharlesSr VP & General CounselNov 28Sale192.7615028,91442,089Dec 02 05:35 PM
FLATLEY JAY TChief Executive OfficerNov 28Sale189.7925,0004,744,761381,262Dec 02 05:35 PM
Bianchi Paul LSr VP, Human ResourcesNov 26Sale189.201,626307,63957,770Nov 26 07:19 PM
WHITFIELD ROY ADirectorNov 17Option Exercise19.614,00078,44015,738Nov 17 07:06 PM
WHITFIELD ROY ADirectorNov 17Sale178.264,000713,04011,738Nov 17 07:06 PM
Stapley MarcSr VP & CFONov 14Option Exercise36.301,42251,61923,533Nov 17 06:52 PM
Stapley MarcSr VP & CFONov 14Sale181.131,422257,56522,111Nov 17 06:52 PM
FLATLEY JAY TChief Executive OfficerNov 13Option Exercise20.0425,000501,000406,262Nov 14 06:06 PM
FLATLEY JAY TChief Executive OfficerNov 13Sale189.3225,0004,732,994381,262Nov 14 06:06 PM
Bouchard MichelChief Accounting OfficerNov 03Option Exercise69.3463143,75424,821Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Option Exercise44.3810,000443,80038,604Nov 05 06:09 PM
Bouchard MichelChief Accounting OfficerNov 03Sale195.68631123,47424,190Nov 05 06:10 PM
Ronaghi MostafaSr VP & CTONov 03Sale195.6610,0001,956,61328,604Nov 05 06:09 PM
BRADBURY DANIELDirectorOct 30Option Exercise42.822,10089,92214,566Oct 31 02:25 PM
BRADBURY DANIELDirectorOct 30Sale191.832,100402,83512,466Oct 31 02:25 PM
Dadswell CharlesSr VP & General CounselOct 27Sale189.8414727,90642,239Oct 28 12:17 PM
FLATLEY JAY TChief Executive OfficerOct 23Option Exercise20.0425,000501,000406,262Oct 24 12:07 PM
FLATLEY JAY TChief Executive OfficerOct 23Sale189.5425,0004,738,446381,262Oct 24 12:07 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Option Exercise43.372,00086,74025,146Oct 16 08:09 PM
Naclerio NicholasSr VP, Corp DevelopmentOct 15Sale147.852,000295,70923,146Oct 16 08:09 PM
Stapley MarcCFOOct 14Option Exercise36.301,42251,61923,533Oct 16 07:49 PM
Stapley MarcCFOOct 14Sale151.481,422215,40322,111Oct 16 07:49 PM
BRADBURY DANIELDirectorOct 13Option Exercise42.822,10089,92214,566Oct 15 07:59 PM
BRADBURY DANIELDirectorOct 13Sale152.032,100319,25712,466Oct 15 07:59 PM
BOWMAN A BLAINEDirectorOct 07Option Exercise19.614,45687,38217,178Oct 07 07:28 PM
BOWMAN A BLAINEDirectorOct 07Sale159.514,456710,77512,722Oct 07 07:28 PM
BRADBURY DANIELDirectorOct 01Option Exercise42.822,10089,92214,566Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Option Exercise69.3463243,82324,822Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Option Exercise44.3810,000443,80038,604Oct 02 04:58 PM
BRADBURY DANIELDirectorOct 01Sale158.882,100333,64012,466Oct 02 04:59 PM
Bouchard MichelChief Accounting OfficerOct 01Sale158.57632100,21824,190Oct 02 04:59 PM
Ronaghi MostafaSr VP & CTOOct 01Sale159.8110,0001,598,08128,604Oct 02 04:58 PM
BOWMAN A BLAINEDirectorSep 30Option Exercise19.615,00098,05017,722Sep 30 07:59 PM
BOWMAN A BLAINEDirectorSep 30Sale164.025,000820,12312,722Sep 30 07:59 PM
Dadswell CharlesSr VP & General CounselSep 29Sale163.7314724,06842,386Sep 30 07:59 PM